BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15520469)

  • 21. Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
    Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Suzuki A; Saigo K; Kawano S; Takenokuchi M; Kumagai S; Matsuo Y; Koizumi T; Takeuchi M
    Eur J Haematol; 2005 Jan; 74(1):11-9. PubMed ID: 15613101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo DNA synthesis by human DNA polymerase lambda, DNA polymerase mu and terminal deoxyribonucleotidyl transferase.
    Ramadan K; Shevelev IV; Maga G; Hübscher U
    J Mol Biol; 2004 May; 339(2):395-404. PubMed ID: 15136041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin diversification in B cell malignancies: internal splicing of heavy chain variable region as a by-product of somatic hypermutation.
    Bende RJ; Aarts WM; Pals ST; van Noesel CJ
    Leukemia; 2002 Apr; 16(4):636-44. PubMed ID: 11960344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. By-products of immunoglobulin somatic hypermutation.
    Bemark M; Neuberger MS
    Genes Chromosomes Cancer; 2003 Sep; 38(1):32-9. PubMed ID: 12874784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal instability of V region hypermutation in the Ramos Burkitt's lymphoma cell line.
    Zhang W; Bardwell PD; Woo CJ; Poltoratsky V; Scharff MD; Martin A
    Int Immunol; 2001 Sep; 13(9):1175-84. PubMed ID: 11526098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA polymerase μ is a global player in the repair of non-homologous end-joining substrates.
    Chayot R; Montagne B; Ricchetti M
    DNA Repair (Amst); 2012 Jan; 11(1):22-34. PubMed ID: 22071146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomologous end joining.
    Nick McElhinny SA; Havener JM; Garcia-Diaz M; Juárez R; Bebenek K; Kee BL; Blanco L; Kunkel TA; Ramsden DA
    Mol Cell; 2005 Aug; 19(3):357-66. PubMed ID: 16061182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal immunoglobulin gene somatic hypermutation in Pol kappa-Pol iota double-deficient mice.
    Shimizu T; Azuma T; Ishiguro M; Kanjo N; Yamada S; Ohmori H
    Immunol Lett; 2005 May; 98(2):259-64. PubMed ID: 15860226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging links between hypermutation of antibody genes and DNA polymerases.
    Gearhart PJ; Wood RD
    Nat Rev Immunol; 2001 Dec; 1(3):187-92. PubMed ID: 11905827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burkitt's lymphoma cell lines producing truncated mu immunoglobulin heavy chains lacking part of the variable region.
    Cogné M; Mounir S; Preud'homme JL; Nau F; Guglielmi P
    Eur J Immunol; 1988 Oct; 18(10):1485-9. PubMed ID: 2847931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smaller role for pol eta?
    Dörner T; Lipsky PE
    Nat Immunol; 2001 Nov; 2(11):982-4. PubMed ID: 11685213
    [No Abstract]   [Full Text] [Related]  

  • 32. Pol zeta ablation in B cells impairs the germinal center reaction, class switch recombination, DNA break repair, and genome stability.
    Schenten D; Kracker S; Esposito G; Franco S; Klein U; Murphy M; Alt FW; Rajewsky K
    J Exp Med; 2009 Feb; 206(2):477-90. PubMed ID: 19204108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes.
    Klein U; Klein G; Ehlin-Henriksson B; Rajewsky K; Küppers R
    Mol Med; 1995 Jul; 1(5):495-505. PubMed ID: 8529116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic hypermutation of the AID transgene in B and non-B cells.
    Martin A; Scharff MD
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12304-8. PubMed ID: 12202747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of DNA polymerase beta accompanies somatic hypermutation in human BL2 cell lines.
    Poltoratsky V; Prasad R; Horton JK; Wilson SH
    DNA Repair (Amst); 2007 Feb; 6(2):244-53. PubMed ID: 17127106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A source of the single-stranded DNA substrate for activation-induced deaminase during somatic hypermutation.
    Wang X; Fan M; Kalis S; Wei L; Scharff MD
    Nat Commun; 2014 Jun; 5():4137. PubMed ID: 24923561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-cycle-regulated DNA double-stranded breaks in somatic hypermutation of immunoglobulin genes.
    Papavasiliou FN; Schatz DG
    Nature; 2000 Nov; 408(6809):216-21. PubMed ID: 11089977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulin VH genes of high-grade mucosa-associated lymphoid tissue lymphomas show a high load of somatic mutations and evidence of antigen-dependent affinity maturation.
    Hallas C; Greiner A; Peters K; Müller-Hermelink HK
    Lab Invest; 1998 Mar; 78(3):277-87. PubMed ID: 9520941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line.
    Sale JE; Neuberger MS
    Immunity; 1998 Dec; 9(6):859-69. PubMed ID: 9881976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Model of Somatic Hypermutation Targeting in Mice Based on High-Throughput Ig Sequencing Data.
    Cui A; Di Niro R; Vander Heiden JA; Briggs AW; Adams K; Gilbert T; O'Connor KC; Vigneault F; Shlomchik MJ; Kleinstein SH
    J Immunol; 2016 Nov; 197(9):3566-3574. PubMed ID: 27707999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.